-
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
Br J Clin Pharmacol. 1979 Dec;8(6):529-37
PMID: 533575
-
The antipyrine test in clinical pharmacology: conceptions and misconceptions.
Clin Pharmacol Ther. 1979 Sep;26(3):275-86
PMID: 111889
-
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Gastroenterology. 1977 May;72(5 Pt 1):924-6
PMID: 849823
-
Influence of inducers and inhibitors on the hydroxylation pattern of N-hexane in rat liver microsomes.
FEBS Lett. 1974 Apr 15;41(1):14-6
PMID: 4852437
-
Regioselective and stereoselective hydroxylation of R and S warfarin by different forms of purified cytochrome P-450 from rabbit liver.
J Biol Chem. 1978 Nov 10;253(21):7813-20
PMID: 701290
-
4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.
Naunyn Schmiedebergs Arch Pharmacol. 1979 Nov;309(2):203-5
PMID: 522906
-
Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
Clin Pharmacol Ther. 1974 Dec;16(6):1059-65
PMID: 4611464
-
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
Pharmacology. 1979;18(4):210-23
PMID: 461498
-
Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Xenobiotica. 1979 Nov;9(11):695-702
PMID: 119355
-
The effect of spironolactone on antipyrine metabolism in man.
Pharmacology. 1973;10(6):338-44
PMID: 4593769
-
The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene.
Mol Pharmacol. 1973 May;9(3):398-404
PMID: 4122821
-
Dose-dependent enzyme induction.
Clin Pharmacol Ther. 1973 Jul-Aug;14(4):514-20
PMID: 4723259
-
The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds.
Biochem Pharmacol. 1966 Jan;15(1):7-18
PMID: 4161076
-
Differences in P-450 cytochromes from livers of rats treated with phenobarbital and with 3-methylcholanthrene.
J Biol Chem. 1973 Mar 25;248(6):2192-201
PMID: 4690601
-
An improved combined gas chromatographic mass spectrometric assay for the estimation of norphenazone in urine.
Biomed Mass Spectrom. 1980 Apr;7(4):179-82
PMID: 7448333
-
Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest.
J Biol Chem. 1977 Jun 10;252(11):3970-9
PMID: 405388
-
Metabolism of drugs. LXX. Further study on antipyrine metabolism.
Chem Pharm Bull (Tokyo). 1971 Jan;19(1):41-5
PMID: 5544367
-
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Clin Pharmacol Ther. 1977 Apr;21(4):470-81
PMID: 849678
-
The fate of antipyrine in man.
J Pharmacol Exp Ther. 1950 Jan;98(1):97-104
PMID: 15403625
-
Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding].
Br J Clin Pharmacol. 1980 Mar;9(3):284P
PMID: 7362740
-
Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase.
J Biol Chem. 1976 Aug 25;251(16):4936-46
PMID: 956169
-
Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings].
Br J Pharmacol. 1980 Jan;68(1):121P
PMID: 7357141
-
Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man.
Biochem Pharmacol. 1974 Jan 15;23(2):197-201
PMID: 4813341
-
Rapid gas-liquid chromatographic estimation of antipyrine in plasma.
J Pharm Pharmacol. 1973 Mar;25(3):205-7
PMID: 4146319
-
Rifampicin and vitamin D metabolism.
Clin Pharmacol Ther. 1980 Jun;27(6):810-4
PMID: 7379450
-
Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):139-45
PMID: 35353